On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

NetworkNewsBreaks – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) Inks LOI with Sundial Growers Inc.

Company: Isodiol International Inc. (ISOLF)
Category: News

Global CBD innovator Isodiol International (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) recently announced that, subject to applicable regulatory approvals, it has signed a Letter of Intent (“LOI”) with Sundial Growers Inc. to import CBD isolate into Canada. Sundial Growers is a privately held Health Canada Access to Cannabis for Medical Purposes Regulations (“ACMPR”) licensed producer and currently operates a 31,000 square foot production facility in Rocky View, Alberta. Per the terms of the agreement, CBD will be imported into Canada through a Health Canada approved Licensed Dealer. Isodiol and Sundial aim to execute a Definitive Supply Agreement which will also be subject to required regulatory approvals. Isodiol’s wholly owned subsidiary, BSPG Laboratories LTD., has received government approval from United Kingdom’s Medicines and Healthcare Products Regulatory Agency for the manufacturing of the active substance CBD, which enables the company to export its pure, natural CBD from the United Kingdom.

To view the full press release, visit http://nnw.fm/K3aLX

About Isodiol International Inc.

Isodiol International Inc. engages in pharmaceutical grade phytochemical compounds and the manufacturing and development of consumer products. Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products and most recently received approval as having the first CBD designated as an Active Pharmaceutical Ingredient as was announced April 26, 2018. Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe. For more information, visit the company’s website at www.Isodiol.com.

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217